Armata Pharmaceuticals Announces Publication of Successful Adjunctive Phage Treatment in Cystic Fibrosis Patienthttps://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-publication-of-successful-adjunctive-phage-treatment-in-cystic-fibrosis-patient-300856592.html
2019-05 University of California San Diego case study of a patient with Pseudomonas aeruginosa
CF: Pseudomonas Infection Resolved with Phage Therapy, Case Suggestshttps://cysticfibrosisnewstoday.com/2019/06/04/armatas-phage-therapy-resolves-multidrug-resistant-pseudomonas-airway-infections-case-report/
2019-05 University of California San Diego case study of a patient with Pseudomonas aeruginosaUse of bacteriophages to treat antibiotic-resistant infections
Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient | SpringerLinkhttps://link.springer.com/article/10.1007/s15010-019-01319-0
2019-05 University of California San Diego case study of a patient with Pseudomonas aeruginosa

Showing topic

2019-05 University of California San Diego case study of a patient with Pseudomonas aeruginosa
AP-PA01Cystic fibrosisMultidrug-resistant (MDR) Pseudomonas aeruginosaUniversity of California San Diego